Skyrizi and Cardiac failure - a phase IV clinical study of FDA data
Summary:
Cardiac failure is reported as a side effect among people who take Skyrizi (risankizumab-rzaa), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Eliquis, and have Psoriasis.
The phase IV clinical study analyzes which people have Cardiac failure when taking Skyrizi. It is created by eHealthMe based on reports of 45,344 people who have side effects when taking Skyrizi from the FDA, and is updated regularly.
What is Skyrizi?
Skyrizi has active ingredients of risankizumab-rzaa. eHealthMe is studying from 45,385 Skyrizi users. Check the latest studies of Skyrizi.
What is Cardiac failure?
Cardiac failure is found to be associated with 2,060 drugs and 2,213 conditions by eHealthMe. Check the latest studies of Cardiac failure.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
45,344 people reported to have side effects when taking Skyrizi.
Among them, 141 people (0.31%) have Cardiac failure.

Among these 141 people:
How long have people been on Skyrizi when they have Cardiac failure? *
What is the gender of people who have Cardiac failure when taking Skyrizi? *
What is the age of people who have Cardiac failure when taking Skyrizi? *
What are other drugs people take besides Skyrizi? *
What are other side effects people have besides Cardiac failure? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Skyrizi and have Cardiac failure?
- Check whether Cardiac failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Skyrizi:
- Skyrizi (45,385 reports)
Cardiac failure treatments and more:
- Cardiac failure (147,157 reports)
How severe was Cardiac failure and when was it recovered:
Expand to all the drugs that have ingredients of risankizumab-rzaa:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Skyrizi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cardiac failure:
- Cardiac failure (2,060 drugs)
Browse all the conditions that are associated with Cardiac failure:
- Cardiac failure (2,213 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on risankizumab-rzaa (the active ingredients of Skyrizi) and Skyrizi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zoladex cause Rheumatoid Arthritis Aggravated? - 7 seconds ago
- Could Klor-Con cause Neuropathy - Peripheral? - 16 seconds ago
- Could Restasis cause Peripheral Vascular Disorder? - 16 seconds ago
- Could Klor-Con cause Peripheral Neuropathy? - 16 seconds ago
- Could Dulcolax cause Movement Disorder? - 18 seconds ago
- Drug interactions of Allopurinol and Metformin - 27 seconds ago
- Could Nexium cause Asthenopia? - 29 seconds ago
- Could Caffeine cause Cough? - 30 seconds ago
- Could Krill cause Eye Pain? - 32 seconds ago
- Could Tenoretic 100 cause Gastroesophageal Reflux Disease? - 36 seconds ago